CELCUITY INC. Net Income
CELCUITY INC. (CELC) reported Net Income of -$78.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-13
- CELCUITY INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$78.86M.
- CELCUITY INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$52.84M.
- CELCUITY INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$50.97M.
- CELCUITY INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$43.80M.
- CELCUITY INC. net income (loss) attributable to parent for fiscal 2025 was -$177.04M.
- CELCUITY INC. net income (loss) attributable to parent for fiscal 2024 was -$111.78M.
- CELCUITY INC. net income (loss) attributable to parent for fiscal 2023 was -$63.78M.
- CELCUITY INC. net income (loss) attributable to parent for fiscal 2022 was -$40.37M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$78.86M 10-Q · filed 2026-08-13 | -$131.71M 10-Q · filed 2026-08-13 | -$182.68M derived: sum of 3 quarters · filed 2026-08-13 | -$226.48M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$52.84M 10-Q · filed 2026-08-13 | -$103.81M derived: sum of 2 quarters · filed 2026-08-13 | -$147.62M derived: sum of 3 quarters · filed 2026-08-13 | -$192.89M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$50.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$94.78M derived: sum of 2 quarters · filed 2026-03-26 | -$140.04M derived: sum of 3 quarters · filed 2026-08-13 | -$177.04M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$43.80M 10-Q · filed 2025-11-13 | -$89.07M derived: sum of 2 quarters · filed 2026-08-13 | -$126.07M 10-Q · filed 2025-11-13 | -$162.72M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$45.27M 10-Q · filed 2026-08-13 | -$82.27M 10-Q · filed 2026-08-13 | -$118.92M derived: sum of 3 quarters · filed 2026-08-13 | -$148.71M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$37.00M 10-Q · filed 2026-08-13 | -$73.65M derived: sum of 2 quarters · filed 2026-08-13 | -$103.44M derived: sum of 3 quarters · filed 2026-08-13 | -$127.16M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2024-12-31 | -$36.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$66.44M derived: sum of 2 quarters · filed 2026-03-26 | -$90.17M derived: sum of 3 quarters · filed 2026-03-26 | -$111.78M 10-K · filed 2026-03-26 | -$111.78M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$29.79M 10-Q · filed 2025-11-13 | -$29.79M 10-Q · filed 2024-11-14 | -$53.51M derived: sum of 2 quarters · filed 2025-11-13 | -$75.13M 10-Q · filed 2025-11-13 | -$75.13M 10-Q · filed 2024-11-14 | -$93.97M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$23.72M 10-Q · filed 2025-11-13 | -$23.72M 10-Q · filed 2024-08-14 | -$45.33M 10-Q · filed 2025-08-14 | -$45.33M 10-Q · filed 2024-08-14 | -$64.18M derived: sum of 3 quarters · filed 2025-11-13 | -$82.59M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-03-31 | -$21.61M 10-Q · filed 2025-11-13 | -$21.61M 10-Q · filed 2024-05-15 | -$40.46M derived: sum of 2 quarters · filed 2025-11-13 | -$58.87M derived: sum of 3 quarters · filed 2025-11-13 | -$73.45M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2023-12-31 | -$18.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$37.25M derived: sum of 2 quarters · filed 2025-03-31 | -$51.84M derived: sum of 3 quarters · filed 2025-03-31 | -$63.78M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$18.40M 10-Q · filed 2024-11-14 | -$32.99M derived: sum of 2 quarters · filed 2024-11-14 | -$44.93M 10-Q · filed 2024-11-14 | -$56.51M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$14.59M 10-Q · filed 2024-11-14 | -$26.53M 10-Q · filed 2024-08-14 | -$38.11M derived: sum of 3 quarters · filed 2024-11-14 | -$49.00M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-03-31 | -$11.94M 10-Q · filed 2024-11-14 | -$23.52M derived: sum of 2 quarters · filed 2024-11-14 | -$34.41M derived: sum of 3 quarters · filed 2024-11-14 | -$44.37M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2022-12-31 | -$11.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$22.48M derived: sum of 2 quarters · filed 2024-03-27 | -$32.44M derived: sum of 3 quarters · filed 2024-03-27 | -$40.37M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$10.89M 10-Q · filed 2023-11-13 | -$20.85M derived: sum of 2 quarters · filed 2023-11-13 | -$28.79M 10-Q · filed 2023-11-13 | -$35.54M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$9.96M 10-Q · filed 2023-11-13 | -$17.89M 10-Q · filed 2023-08-11 | -$24.65M derived: sum of 3 quarters · filed 2023-11-13 | -$30.68M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-03-31 | -$7.93M 10-Q · filed 2023-11-13 | -$14.69M derived: sum of 2 quarters · filed 2023-11-13 | -$20.72M derived: sum of 3 quarters · filed 2023-11-13 | -$34.75M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2021-12-31 | -$6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$12.78M derived: sum of 2 quarters · filed 2023-03-23 | -$26.81M derived: sum of 3 quarters · filed 2023-03-23 | -$29.61M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$6.03M 10-Q · filed 2022-11-10 | -$20.06M derived: sum of 2 quarters · filed 2022-11-10 | -$22.85M 10-Q · filed 2022-11-10 | -$25.40M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$14.03M 10-Q · filed 2022-11-10 | -$16.82M 10-Q · filed 2022-08-12 | -$19.38M derived: sum of 3 quarters · filed 2022-11-10 | -$21.85M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-03-31 | -$2.79M 10-Q · filed 2022-11-10 | -$5.34M derived: sum of 2 quarters · filed 2022-11-10 | -$7.82M derived: sum of 3 quarters · filed 2022-11-10 | -$10.02M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2020-12-31 | -$2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$5.03M derived: sum of 2 quarters · filed 2022-03-23 | -$7.23M derived: sum of 3 quarters · filed 2022-03-23 | -$9.47M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | -$2.47M 10-Q · filed 2021-11-09 | -$4.68M derived: sum of 2 quarters · filed 2021-11-09 | -$6.92M 10-Q · filed 2021-11-09 | -$8.73M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | -$2.20M 10-Q · filed 2021-11-09 | -$4.45M 10-Q · filed 2021-08-11 | -$6.26M derived: sum of 3 quarters · filed 2021-11-09 | -$8.24M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-03-31 | -$2.25M 10-Q · filed 2021-11-09 | -$4.06M derived: sum of 2 quarters · filed 2021-11-09 | -$6.04M derived: sum of 3 quarters · filed 2021-11-09 | -$7.76M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2019-12-31 | -$1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$3.79M derived: sum of 2 quarters · filed 2021-02-16 | -$5.51M derived: sum of 3 quarters · filed 2021-02-16 | -$7.36M 10-K · filed 2021-02-16 | ||||
| 2019-09-30 | -$1.98M 10-Q · filed 2020-11-09 | -$3.70M derived: sum of 2 quarters · filed 2020-11-09 | -$5.55M 10-Q · filed 2020-11-09 | -$7.38M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$1.72M 10-Q · filed 2020-11-09 | -$3.57M 10-Q/A · filed 2020-08-11 | -$5.39M derived: sum of 3 quarters · filed 2020-11-09 | -$7.26M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-03-31 | -$1.85M 10-Q · filed 2020-11-09 | -$3.67M derived: sum of 2 quarters · filed 2020-11-09 | -$5.54M derived: sum of 3 quarters · filed 2020-11-09 | -$7.36M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2018-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$3.70M derived: sum of 2 quarters · filed 2020-03-13 | -$5.51M derived: sum of 3 quarters · filed 2020-03-13 | -$7.48M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | -$1.87M 10-Q · filed 2019-11-07 | -$3.69M derived: sum of 2 quarters · filed 2019-11-07 | -$5.66M 10-Q · filed 2019-11-07 | -$7.38M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$1.82M 10-Q · filed 2019-11-07 | -$3.78M 10-Q · filed 2019-08-08 | -$5.51M derived: sum of 3 quarters · filed 2019-11-07 | -$7.27M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-03-31 | -$1.97M 10-Q · filed 2019-11-07 | -$3.69M derived: sum of 2 quarters · filed 2019-11-07 | -$5.46M derived: sum of 3 quarters · filed 2019-11-07 | -$7.23M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2017-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$3.49M derived: sum of 2 quarters · filed 2019-03-01 | -$5.26M derived: sum of 3 quarters · filed 2019-03-01 | -$6.25M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | -$1.76M 10-Q · filed 2018-11-13 | -$3.54M derived: sum of 2 quarters · filed 2018-11-13 | -$4.53M 10-Q · filed 2018-11-13 | -$5.43M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$1.78M 10-Q · filed 2018-08-09 | -$2.76M 10-Q · filed 2018-08-09 | -$3.67M derived: sum of 3 quarters · filed 2018-08-09 | -$4.53M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$987.35K 10-Q · filed 2018-05-14 | -$1.89M derived: sum of 2 quarters · filed 2018-05-14 | -$2.76M derived: sum of 3 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | -$902.43K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$1.77M derived: sum of 2 quarters · filed 2018-03-15 | -$3.31M 10-K · filed 2018-03-15 | |||||
| 2016-09-30 | -$868.52K 10-Q · filed 2017-12-01 | -$2.41M 10-Q · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |